Mutation analysis of protein kinase A catalytic subunit in thyroid adenomas and pituitary turnouts

European Journal of Endocrinology

Volumn 141, Issue 4, 1999, Pages 409-412

  Esapa, Christopher T ^a   Harris, Philip E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; THYROTROPIN; THYROTROPIN RECEPTOR;

ARTICLE; CODON; GENE MUTATION; HUMAN; HUMAN TISSUE; HYBRIDIZATION; HYPOPHYSIS TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; THYROID ADENOMA; THYROID NODULE;

EID: 0032723515     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410409     Document Type: Article

References (19)

1. Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gsα genes as a cause of toxic thyroid adenomas. Journal of Clinical Endocrinology and Metabolism 1997 82 2695-2701.
2. Duprez L, Parma J, Van Sande J, Rodien P, Dumont JE, Vassart G et al. TSH receptor mutations and thyroid disease. Trends in Endocrinology and Metabolism 1998 9 133-140.
3. Suarez HG. Genetic alterations in human epithelial thyroid tumours. Clinical Endocrinology 1998 48 531-546.
4. Polak M. Activating mutations of the thyrotropin receptor: a short review with emphasis on some pediatric aspects. European Journal of Endocrinology 1998 138 353-357.
5. Esapa C, Foster S, Johnson S, Jameson JL, Kendall-Taylor P & Harris PE. G protein and thyrotropin receptor mutations in thyroid neoplasia. Journal of Clinical Endocrinology and Metabolism 1997 82 493-496.
6. Matsuo K, Friedman E, Gejman PV & Fagin JA. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the α-subunit of Gs in human thyroid neoplasms. Journal of Clinical Endocrinology and Metabolism 1993 76 1446-1451.
7. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C & Monier R. Gsp mutations in human thyroid tumors. Oncogene 1991 6 677-679.
8. Yoshimoto K, Iwahana H, Fukuda A, Sano T & Itakura M. Rare mutations of the Gsα subunit gene in human endocrine tumors. Cancer 1993 72 1386-1393.
9. Said S, Schlumberger M & Suarez HG. Oncogenes and antioncogenes in human epithelial thyroid tumors. Journal of Endocrinological Investigation 1994 17 371-379.
10. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR & Vallar L. GTPase inhibiting mutations activate the a chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989 340 692-696.
11. Clementi E, Malgaretti N, Meldolesi J & Taramelli R. A new constitutively activating mutation of the Gs protein α subunit-gsp oncogene is found in human pituitary tumours. Oncogene 1990 5 1059-1061.
12. Tordjman K, Stern N. Ouaknine G, Yossiphov Y, Razon N, Nordenskjold M et al. Activating mutations of the Gsα-gene in non-functioning pituitary tumours. Journal of Clinical Endocrinology and Metabolism 1993 77 765-769.
13. Williamson EA, Daniels M, Foster S, Kelly WF, Kendall-Taylor P & Harris PE. Gsα and Gi2α mutations in clinically non-functioning pituitary tumours. Clinical Endocrinology 1994 41 815-820.
14. Williamson EA, Ince PG, Harrison D, Kendall-Taylor P & Harris PE. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. European Journal of Clinical Investigation 1995 25 128-131.
15. Bertherat J, Chanson P & Montminy. The cyclic adenosine 3′-5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Molecular Endocrinology 1995 9 777-783.
16. Orellana SA & McKnight GS. Mutations in the catalytic subunit of cAMP-dependent protein kinase results in unregulated biological activity. Proceedings of the National Academy of Sciences of the USA 1992 89 4726-4730.
17. Harris PE. Gs protein mutations and the pathogenesis and function of pituitary tumors. Metabolism 1996 45 120-122.
18. Nemoz G, Sette C, Hess M, Muca C, Vallar L & Conti M. Activation of cyclic nucleotide phosphodiesterases in FRTL5 thyroid cells expressing a constitutively active Gsα. Molecular Endocrinology 1995 9 1279-1287.
19. Lania A, Persani L, Ballar ÈE, Mantovani S, Losa M & Spada A. Constitutively active Gsα is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas. Journal of Clinical Endocrinology and Metabolism 1998 83 1624-1628.